Crystal Adam — SEC insider filings

SEC reporting owner CIK 1825445. 32 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2021-02-16 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)President, R&D20—26 legs · 372,669 sh · $7,438,73430
C4 Therapeutics, Inc. (CCCC)Chief Medical Officer12—10 legs · 75,000 sh · $2,967,60823

Insider filings — Crystal Adam

FiledFormIssuerReported transactionsSource
2026-11-134Tango Therapeutics, Inc. (TNGX)Option exercise (M): 5,000 @ $2.91 · Sale (S): 5,000 @ $25 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-11-044Tango Therapeutics, Inc. (TNGX)Option exercise (M): 5,000 @ $2.91 · Sale (S): 3,900 @ $22.26 · Sale (S): 1,100 @ $22.99 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-10-054Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 26,400 @ $24.45 · Sale (S): 600 @ $25.32 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-09-034Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 27,000 @ $22.37 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-08-054Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 5,267 @ $26.79 · Sale (S): 21,733 @ $27.35 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-07-024Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 19,629 @ $29.34 · Sale (S): 7,371 @ $30.25 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-06-034Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 6,140 @ $22.25 · Sale (S): 20,860 @ $23.06 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-05-054Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 25,900 @ $21.19 · Sale (S): 1,100 @ $22.00 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-04-164Tango Therapeutics, Inc. (TNGX)Option exercise (M): 38,460 @ $5.20 · Sale (S): 38,460 @ $25 · Option exercise (M): 38,460 (derivative) @ $0EDGAR
2026-04-024Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 27,000 @ $21.20 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-03-274Tango Therapeutics, Inc. (TNGX)Option exercise (M): 12,000 @ $5.20 · Sale (S): 12,000 @ $20.11 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2026-03-094Tango Therapeutics, Inc. (TNGX)Sale (S): 20,251 @ $15EDGAR
2026-02-274Tango Therapeutics, Inc. (TNGX)Sale (S): 54,345 @ $12.77EDGAR
2026-02-044Tango Therapeutics, Inc. (TNGX)Grant/award (A): 47,460 @ $0 · Sale (S): 18,251 @ $12.26 · Sale (S): 201 @ $12.90 · Grant/award (A): 284,760 (derivative) @ $0EDGAR
2025-02-064Tango Therapeutics, Inc. (TNGX)Sale (S): 7,432 @ $2.99 · Sale (S): 6,851 @ $3.16EDGAR
2025-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 53,015 @ $0 · Grant/award (A): 318,090 (derivative) @ $0EDGAR
2024-02-084Tango Therapeutics, Inc. (TNGX)Sale (S): 4,288 @ $12.56 · Sale (S): 4,083 @ $12.62EDGAR
2024-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 46,599 @ $0 · Grant/award (A): 279,593 (derivative) @ $0EDGAR
2023-11-024Tango Therapeutics, Inc. (TNGX)Sale (S): 7,507 @ $8.39EDGAR
2023-03-024Tango Therapeutics, Inc. (TNGX)Grant/award (A): 81,250 @ $0 · Grant/award (A): 487,500 (derivative) @ $0EDGAR
2023-02-014C4 Therapeutics, Inc. (CCCC)Option exercise (M): 3,750 · Tax withholding (F): 1,301 @ $7.78 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2022-06-144/AC4 Therapeutics, Inc. (CCCC)Tax withholding (F): 1,102 @ $7.01EDGAR
2022-05-274C4 Therapeutics, Inc. (CCCC)Option exercise (M): 3,750 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2022-02-164C4 Therapeutics, Inc. (CCCC)Grant/award (A): 118,000 (derivative) @ $0 · Grant/award (A): 26,250 (derivative) @ $0EDGAR
2022-01-054C4 Therapeutics, Inc. (CCCC)Option exercise (M): 15,000 @ $6.49 · Sale (S): 13,946 @ $31.59 · Sale (S): 1,054 @ $32.66 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-12-234C4 Therapeutics, Inc. (CCCC)Option exercise (M): 5,000 @ $6.49 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-10-124C4 Therapeutics, Inc. (CCCC)Option exercise (M): 10,000 @ $6.49 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-10-054C4 Therapeutics, Inc. (CCCC)Option exercise (M): 15,000 @ $4.98 · Sale (S): 1,712 @ $44.25 · Sale (S): 8,176 @ $45.32 · Sale (S): 5,112 @ $45.99 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-08-024C4 Therapeutics, Inc. (CCCC)Option exercise (M): 15,000 @ $4.98 · Sale (S): 15,000 @ $45 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-07-064C4 Therapeutics, Inc. (CCCC)Option exercise (M): 15,000 @ $6.50 · Sale (S): 13,300 @ $37.93 · Sale (S): 1,700 @ $38.38 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-04-064C4 Therapeutics, Inc. (CCCC)Option exercise (M): 15,000 @ $6.50 · Sale (S): 4,121 @ $37.16 · Sale (S): 10,879 @ $38.00 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-02-164C4 Therapeutics, Inc. (CCCC)Grant/award (A): 87,850 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1825445 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs